To innovate and lead the development of cutting-edge macromolecular ophthalmic drugs, aiming to become a unicorn enterprise. Rooted in our values of focus, innovation, compassion, and responsibility, we are committed to provide affordable and long-lasting treatment solutions for patients with retinal diseases worldwide.